U.S. retail pharmacies struggling with vaccine administration as demand surges

Despite a strong supply, U.S. retail pharmarcies are, in some places, struggling to quickly administer COVID-19 vaccines, The Wall Street Journal reports.
Some Americans are facing "waits of days or weeks for doses as local health officials hustle to improve access to meet surging demand," the Journal writes, noting chains like CVS, Walgreens, and Walmart have been increasingly unable to accomodate walk-ins.
Health officials attribute the jolt in vaccine interest to recent booster eligibility for millions, newly-recommended use in children as young as five, and concerns about the new Omicron variant, per the Journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Demand for vaccinations is particularly high at this time so we encourage people to schedule their appointments in advance," Walgreens said. Retail pharmacies, who have provided roughly two-thirds of the country's COVID vaccinations, continue to embrace their inoculation responsibility, but are struggling with staffing, the Journal notes, causing "some locations to limit hours or close drive-throughs."
CVS said it has open slots and enough doses for the next two weeks, but in-store waits or pre-scheduled appointments may be necessary. The chain told the Journal it had recently hired thousands of pharmacists, pharmacist technicians, and other workers to help with COVID testing and vaccine administration.
Confusion over which drugstores allow walk-ins — which some Walmart pharmacies, for example, stopped offering due to overwhelming demand — is also adding to the problem, local health officials told the Journal. The White House on Thursday said the federal pharmacy partnership is working to expand availability.
"That message to just go ahead and walk in might be appealing," said Dr. Matt Willis, public health officer for Marin County, Calif., "but it doesn't work very well."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Quiz of The Week: 1 - 7 March
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Superboys of Malegaon: 'uplifting' Indian love letter to scrappy filmmaking
The Week Recommends 'Feelgood' comedy about a group of friends who make their own versions of Bollywood hits
By The Week UK Published
-
The week's best photos
In Pictures Rio’s dirtiest party, a pancake-flipping race, and more
By Anahi Valenzuela, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published